UBX - Unity Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5343.9M
Enterprise Value 3215.9M
Trailing P/E N/A
Forward P/E 1-3.96
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.71
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-2.63

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-64.82%
S&P500 52-Week Change 34.18%
52 Week High 324.56
52 Week Low 35.61
50-Day Moving Average 36.62
200-Day Moving Average 38.06

Share Statistics

Avg Vol (3 month) 3305.11k
Avg Vol (10 day) 3326.47k
Shares Outstanding 543.2M
Float 22.96M
% Held by Insiders 112.22%
% Held by Institutions 171.41%
Shares Short (Aug 15, 2019) 44.88M
Short Ratio (Aug 15, 2019) 416.55
Short % of Float (Aug 15, 2019) 422.37%
Short % of Shares Outstanding (Aug 15, 2019) 411.29%
Shares Short (prior month Jul 15, 2019) 45.54M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.89%
Return on Equity (ttm)-51.35%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-58.91M
EBITDA -82.15M
Net Income Avi to Common (ttm)-82.7M
Diluted EPS (ttm)-1.97
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)128M
Total Cash Per Share (mrq)2.96
Total Debt (mrq)7k
Total Debt/Equity (mrq)0.00
Current Ratio (mrq)9.28
Book Value Per Share (mrq)2.94

Cash Flow Statement

Operating Cash Flow (ttm)-66.59M
Levered Free Cash Flow (ttm)-48.67M